Collegium Pharmaceutical(COLL) - 2025 Q4 - Annual Report
Collegium PharmaceuticalCollegium Pharmaceutical(US:COLL)2026-02-26 12:34
Transcript
Slide

Table of Contents Collegium Pharmaceutical, Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37372 Virginia (State or other jurisdiction of ...